A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)

NCT07202728 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1489

Last updated 2025-10-02

No results posted yet for this study

Summary

This observational study aims to establish a national cohort of patients with hydatidiform mole (molar pregnancy) to investigate its malignant transformation rate and malignant transformation mechanisms, with the goal of developing and promoting precision diagnosis and treatment models across China.

Conditions

  • Hydatidiform Mole

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Hebei Medical University Third Hospital

    collaborator OTHER
  • Hainan women and children medical center

    collaborator UNKNOWN
  • Shenzhen Maternity & Child Healthcare Hospital

    collaborator OTHER
  • Third Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER
  • International Peace Maternity and Child Health Hospital

    collaborator OTHER
  • Shandong University

    collaborator OTHER
  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Gansu Provincial Maternity and Child-care Hospital/Gansu Provincial Central Hospital

    collaborator UNKNOWN
  • Dalian women and children's medical group

    collaborator UNKNOWN
  • Obstetrics & Gynecology Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Xin Lu, MD & PhD · Obstetrics & Gynecology Hospital of Fudan University

  • Yang Xiang, MD & PhD · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-09
Primary Completion
2028-08-30
Completion
2030-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07202728 on ClinicalTrials.gov